Abstract
Multidrug resistance (MDR) mediated by overexpression of MDR1 (ABCB1) P-glycoprotein (Pgp) is one of the best characterized transporter-mediated barriers to successful chemotherapy in cancer patients and is also a rapidly emerging target in the progression of neurodegenerative disorders, such as Alzheimers and Parkinsons diseases. Therefore, molecular imaging probes capable of imaging noninvasively Pgp and closely related transporter activities in tissues as well as tumors would be expected to contribute to personalized medicine. Interrogation of Pgp-mediated transport activity in vivo via noninvasive SPECT imaging could be beneficial for stratification of patient populations likely to benefit from a given therapeutic treatment, assist in the management of chemotherapy and aid the study of neurodegenerative diseases.
Keywords: Multidrug resistance, ABC transporters, P-glycoprotein, SPECT, PET, metal complexes, radiopharmaceuticals, technetium-99m, blood-brain barrier, cancer, gene therapy, ATP-binding cassette (ABC), Transmembrane domains, Nucleotide-binding domains (NBDs), 99mTc-Sestamibi, Pgp expression, Verapamil, Cyclosporin, Pgp inhibitors, Quinidine, Q-complexes, 99mTc-Furifosmin, PSC 833, LY335979, Pgp activity, Pgp substrate, Schiff-base Ga(III) complexes, Multiple myeloma (MM), valspodar, Tariquidar, Parkinsonian syndrome, 11C-verapamil, Alzheimer's Disease (AD), Creutzfeldt-Jakob disease
Current Topics in Medicinal Chemistry
Title: Probing Multidrug Resistance P-glycoprotein Transporter Activity with SPECT Radiopharmaceuticals
Volume: 10 Issue: 17
Author(s): David Piwnica-Worms and Vijay Sharma
Affiliation:
Keywords: Multidrug resistance, ABC transporters, P-glycoprotein, SPECT, PET, metal complexes, radiopharmaceuticals, technetium-99m, blood-brain barrier, cancer, gene therapy, ATP-binding cassette (ABC), Transmembrane domains, Nucleotide-binding domains (NBDs), 99mTc-Sestamibi, Pgp expression, Verapamil, Cyclosporin, Pgp inhibitors, Quinidine, Q-complexes, 99mTc-Furifosmin, PSC 833, LY335979, Pgp activity, Pgp substrate, Schiff-base Ga(III) complexes, Multiple myeloma (MM), valspodar, Tariquidar, Parkinsonian syndrome, 11C-verapamil, Alzheimer's Disease (AD), Creutzfeldt-Jakob disease
Abstract: Multidrug resistance (MDR) mediated by overexpression of MDR1 (ABCB1) P-glycoprotein (Pgp) is one of the best characterized transporter-mediated barriers to successful chemotherapy in cancer patients and is also a rapidly emerging target in the progression of neurodegenerative disorders, such as Alzheimers and Parkinsons diseases. Therefore, molecular imaging probes capable of imaging noninvasively Pgp and closely related transporter activities in tissues as well as tumors would be expected to contribute to personalized medicine. Interrogation of Pgp-mediated transport activity in vivo via noninvasive SPECT imaging could be beneficial for stratification of patient populations likely to benefit from a given therapeutic treatment, assist in the management of chemotherapy and aid the study of neurodegenerative diseases.
Export Options
About this article
Cite this article as:
Piwnica-Worms David and Sharma Vijay, Probing Multidrug Resistance P-glycoprotein Transporter Activity with SPECT Radiopharmaceuticals, Current Topics in Medicinal Chemistry 2010; 10 (17) . https://dx.doi.org/10.2174/156802610792928086
DOI https://dx.doi.org/10.2174/156802610792928086 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Call for Papers in Thematic Issues
Chemistry Based on Natural Products for Therapeutic Purposes
The development of new pharmaceuticals for a wide range of medical conditions has long relied on the identification of promising natural products (NPs). There are over sixty percent of cancer, infectious illness, and CNS disease medications that include an NP pharmacophore, according to the Food and Drug Administration. Since NP ...read more
Current Trends in Drug Discovery Based on Artificial Intelligence and Computer-Aided Drug Design
Drug development discovery has faced several challenges over the years. In fact, the evolution of classical approaches to modern methods using computational methods, or Computer-Aided Drug Design (CADD), has shown promising and essential results in any drug discovery campaign. Among these methods, molecular docking is one of the most notable ...read more
Drug Discovery in the Age of Artificial Intelligence
In the age of artificial intelligence (AI), we have witnessed a significant boom in AI techniques for drug discovery. AI techniques are increasingly integrated and accelerating the drug discovery process. These developments have not only attracted the attention of academia and industry but also raised important questions regarding the selection ...read more
From Biodiversity to Chemical Diversity: Focus of Flavonoids
Flavonoids are the largest group of polyphenols, plant secondary metabolites arising from the essential aromatic amino acid phenylalanine (or more rarely from tyrosine) via the phenylpropanoid pathway. The flavan nucleus is the basic 15-carbon skeleton of flavonoids (C6-C3-C6), which consists of two phenyl rings (A and B) and a heterocyclic ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Deep Eutectic Solvents: An Alternative Medium for the Preparation of Organosulfur Compounds
Current Green Chemistry Application of NMR Spectroscopy in Medicinal Chemistry and Drug Discovery
Current Topics in Medicinal Chemistry Therapeutic Strategies for the Treatment of Spinal Muscular Atrophy (SMA) Disease
Current Genomics Editorial (Thematic Issue: Ceramics, Nanotubes, Advanced Materials: Theoretical and Experimental Structure-Property Relationships Part IV)
Current Physical Chemistry Commentary (Research Highlights)
CNS & Neurological Disorders - Drug Targets Immunomodulatory Lactoferrin in the Regulation of Apoptosis Modulatory Proteins in Cancer
Protein & Peptide Letters Current Status and Perspectives in Ceramide-Targeting Molecular Medicine
Current Pharmaceutical Design The Immunoproteasome: An Emerging Therapeutic Target
Current Topics in Medicinal Chemistry Brain local and regional neuroglial alterations in Alzheimer´s Disease: cell types, responses and implications.
Current Alzheimer Research Pin1: A New Outlook in Alzheimers Disease
Current Alzheimer Research Current Therapeutic Options for Alzheimers Disease
Current Genomics P2Y Receptors: Focus on Structural, Pharmacological and Functional Aspects in the Brain
Current Medicinal Chemistry Flavones as a Privileged Scaffold in Drug Discovery: Current Developments
Current Organic Synthesis Therapeutic Nucleic Acids
Recent Patents on Regenerative Medicine Necroptosis: Who Knew There were so Many Interesting Ways to Die?
CNS & Neurological Disorders - Drug Targets PPAR-γ: Therapeutic Prospects in Parkinson's Disease
Current Drug Targets Neurotrophic Factors for the Investigation and Treatment of Movement Disorders
Current Medicinal Chemistry - Central Nervous System Agents Dehydroepiandrosterone (DHEA) and its Sulphate (DHEAS) in Alzheimer’s Disease
Current Alzheimer Research Glutamate Transporter GLT-1 as a Therapeutic Target for Substance Use Disorders
CNS & Neurological Disorders - Drug Targets Experimental Developments and Review of Recent Patents for the Repair of Skeletal Muscles by Methods of Regenerative Medicine
Recent Patents on Regenerative Medicine